Products
Online Inquiry
Dehydrodiisoeugenol
Cat. No.:
0225LY-1316
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Dehydrodiisoeugenol exerts anti-inflammatory effects by suppressing the expression of COX-2 and inhibiting the transcriptional activity of NF-kB and the proteolysis of inhibitor kB-alpha in stimulated macrophages.
Synonym:
2680-81-1; Diisoeugenol, dehydro-; Isoeugenol, dehydrodi-; 4-[(2R,3R)-2,3-Dihydro-7-methoxy-3-methyl-5-[(E)-1-propenyl]benzofuran-2-yl]-2-methoxyphenol; Phenol, 4-(2,3-dihydro-7-methoxy-3-methyl-5-propenyl-2-benzofuranyl)-2-methoxy-; 2-Methoxy-4-(7-methoxy-3-methyl-5-(prop-1-en-1-yl)-2,3-dihydrobenzofuran-2-yl)phenol; Phenol, 4-[2,3-dihydro-7-methoxy-3-methyl-5-(1-propenyl)-2-benzofuranyl]-2-methoxy-
CAS No.:
2680-81-1
Compound CID:
5379033
Formula:
C20H22O4
Formula Weight:
326.39
Specification
Relative Density:
1.16 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Dehydrodiisoeugenol can be used in inflammation research to investigate the inhibition of the NF-kappaB signaling pathway.
Library Information
Target:
COX; NF-κB
Receptor:
COX; NF-κB
Pathways:
Microbiology/Virology; Immunology/Inflammation; Neuronal signaling; NF-κB
Plate Number:
AOCL-17
Plate Location:
h3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
59 mg/mL; 180.77 mM
Solubility:
Soluble in chloroform, dichloromethane, ethyl acetate, acetone, etc.
